These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 3798123)

  • 1. Management of hormone responsive diseases. Proceedings of the third international conference. June 7, 1986, Rotterdam, The Netherlands.
    Semin Oncol; 1986 Dec; 13(4 Suppl 4):1-43. PubMed ID: 3798123
    [No Abstract]   [Full Text] [Related]  

  • 2. Megestrol acetate v tamoxifen in advanced breast cancer in postmenopausal patients.
    Morgan LR
    Semin Oncol; 1985 Mar; 12(1 Suppl 1):43-7. PubMed ID: 3975652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progesterone receptor level as a predictor of response to megestrol acetate in advanced breast cancer: a retrospective study.
    Johnson PA; Bonomi PD; Anderson KM; Wolter JM; Bacon LD; Rossof AH; Economou SG
    Cancer Treat Rep; 1983; 67(7-8):717-20. PubMed ID: 6871887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Megestrol acetate in the treatment of advanced post-menopausal breast cancer.
    Benghiat A; Cassidy SA; Davidson HE; Mancero FS; Pickard JG; Tyrrell CJ
    Eur J Surg Oncol; 1986 Mar; 12(1):43-5. PubMed ID: 3956753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Megestrol acetate v tamoxifen in advanced breast cancer: a phase III trial of the Piedmont Oncology Association (POA).
    Muss HB; Paschold EH; Black WR; Cooper MR; Capizzi RL; Christian R; Cruz JM; Jackson DV; Stuart JJ; Richards F
    Semin Oncol; 1985 Mar; 12(1 Suppl 1):55-61. PubMed ID: 3883503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Appetite increase and weight gain following treatment with megestrol acetate in patients with advanced cancer].
    Marcos Sánchez F; Juárez Ucelay F; Aparicio Martínez JC; Durán Pérez-Navarro A
    An Med Interna; 1994 Aug; 11(8):415-6. PubMed ID: 7772697
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of megestrol acetate in advanced breast cancer on a single-daily-dose schedule.
    Carpenter JT; Peterson L
    Semin Oncol; 1985 Mar; 12(1 Suppl 1):40-2. PubMed ID: 3975651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transvaginal sonography in a woman treated with megestrol acetate for breast cancer.
    Lazebnik N; Hill LM; Robinson TM
    J Ultrasound Med; 1994 Aug; 13(8):652-4. PubMed ID: 7933037
    [No Abstract]   [Full Text] [Related]  

  • 9. Primary hormonal therapy of advanced breast cancer with megestrol acetate: predictive value of estrogen receptor and progesterone receptor levels.
    Bonomi P; Johnson P; Anderson K; Wolter J; Bunting N; Strauss A; Roseman D; Shorey W; Economou S
    Semin Oncol; 1985 Mar; 12(1 Suppl 1):48-54. PubMed ID: 3975653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical results with megestrol acetate in patients with advanced carcinoma of the breast.
    Ansfield FJ; Kallas GJ; Singson JP
    Surg Gynecol Obstet; 1982 Dec; 155(6):888-90. PubMed ID: 7147170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Megestrol acetate flare.
    Greenwald ES
    Cancer Treat Rep; 1983 Apr; 67(4):405. PubMed ID: 6850658
    [No Abstract]   [Full Text] [Related]  

  • 12. Hyperglycemia secondary to megestrol acetate for endometrial neoplasia.
    Rose PG
    Gynecol Oncol; 1996 Apr; 61(1):139-41. PubMed ID: 8626102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of megestrol acetate in cats.
    Romatowski J
    J Am Vet Med Assoc; 1989 Mar; 194(5):700-2. PubMed ID: 2647696
    [No Abstract]   [Full Text] [Related]  

  • 14. Progestin therapy in lesions of the endometrium.
    Wentz WB
    Semin Oncol; 1985 Mar; 12(1 Suppl 1):23-7. PubMed ID: 3975648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Megestrol acetate.
    Canetta R; Florentine S; Hunter H; Lenaz L
    Cancer Treat Rev; 1983 Sep; 10(3):141-57. PubMed ID: 6352021
    [No Abstract]   [Full Text] [Related]  

  • 16. Megestrol acetate for the palliation of advanced ovarian carcinoma.
    Geisler HE
    Obstet Gynecol; 1983 Jan; 61(1):95-8. PubMed ID: 6185891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dramatic prostate specific antigen decrease in response to discontinuation of megestrol acetate in advanced prostate cancer: expansion of the antiandrogen withdrawal syndrome.
    Dawson NA; McLeod DG
    J Urol; 1995 Jun; 153(6):1946-7. PubMed ID: 7538601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of action of progestational agents.
    Allegra JC; Kiefer SM
    Semin Oncol; 1985 Mar; 12(1 Suppl 1):3-5. PubMed ID: 3975649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Megestrol acetate as hormone therapy in oncology].
    Berstein LM
    Vopr Onkol; 1998; 44(2):142-8. PubMed ID: 9615815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Megestrol acetate oral suspension.
    Porche DJ
    J Assoc Nurses AIDS Care; 1994; 5(4):35-6, 44. PubMed ID: 7948971
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.